Oct 12 2026 Global law firm Freshfields has advised Asieris Pharmaceuticals, a global innovative biopharmaceutical company focused on genitourinary tumours and women’s health, on its conditional exclusive license agreement with Theramex, a global specialty pharmaceutical company dedicated to women and their health, relating to CEVIRA® (APL-1702), a photodynamic drug-device combination product being developed as a potential first-in-class non-surgical treatment for high-grade cervical lesions...
